Genetic alterations in prostate cancer as diagnostic and prognostic markers

被引：0
|
作者：
Saeidi, Hamidreza [1 ]
Ismail, Patimah [1 ]
Samudi Raju, Chandramathi [2 ]
Khairul-Asri, Mohd Ghani [3 ]
Bakrin, Ikmal Hisyam [4 ]
机构：
[1] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Malaysia
[2] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia
[3] Univ Putra Malaysia, Dept Urol, Fac Med & Hlth Sci, Seri Kembangan, Selangor, Malaysia
[4] Putra Malaysia Univ, Dept Pathol, Fac Med & Hlth Sci, Serdang, Malaysia
来源：
MALAYSIAN JOURNAL OF PATHOLOGY | 2023年 / 45卷 / 02期
关键词：
Prostate cancer; genetic alterations; diagnostic markers; prognostic markers; EARLY PSA RECURRENCE; GERMLINE MUTATIONS; SPOP MUTATIONS; PTEN LOSS; MEN; ABIRATERONE; OUTCOMES; FUSION; TP53; RISK;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Prostate cancer is the second-most frequently diagnosed cancer in men worldwide. Serum prostate-specific antigen is currently used for the early detection of prostate cancer. However, new biomarkers are needed to decrease over diagnosis and over treatment of prostate cancer due to limitations of prostate-specific antigen. Recently, molecular biomarkers have shown promising results for diagnosis and prognosis of prostate cancer. Molecular biomarkers have improved the sensitivity and specificity of prostate-specific antigen and studies are ongoing to identify molecular biomarkers as a replacement for prostate-specific antigen. This review aims to give an overview of emerging molecular biomarkers for diagnosis and prognosis of prostate cancer.
引用
收藏
页码：149 / 155
页数：7
相关论文
共 50 条
  • [1] Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers
    Taccaliti, A.
    Silvetti, F.
    Palmonella, G.
    Boscaro, M.
    CURRENT GENOMICS, 2011, 12 (08) : 618 - 625
  • [2] STUDY OF GENETIC AND EPIGENETIC ALTERATIONS IN URINE SAMPLES AS DIAGNOSTIC MARKERS FOR PROSTATE CANCER
    Kalogeropoulos, T.
    Dimitriadis, E.
    Klapsas, V
    Sotiriou, S.
    Koutsiaris, E.
    Fasoulis, L.
    Kyriazogloy, A.
    Pandis, N.
    Thanos, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 576 - 576
  • [3] Study of Genetic and Epigenetic Alterations in Urine Samples as Diagnostic Markers for Prostate Cancer
    Dimitriadis, Efthymios
    Kalogeropoulos, Theodoros
    Velaeti, Stamatia
    Sotiriou, Sotirios
    Vassiliou, Evangelos
    Fasoulis, Loukas
    Klapsas, Vasilios
    Synesiou, Michalis
    Apostolaki, Aikaterini
    Trangas, Theoni
    Pandis, Nikolaos
    ANTICANCER RESEARCH, 2013, 33 (01) : 191 - 197
  • [4] Diagnostic and prognostic markers for human prostate cancer
    Gao, X
    Porter, AT
    Grignon, DJ
    Pontes, JE
    Honn, KV
    PROSTATE, 1997, 31 (04): : 264 - 281
  • [5] Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets
    Gurel, Bora
    Iwata, Tsuyoshi
    Koh, Cheryl M.
    Yegnasubramanian, Srinivasan
    Nelson, William G.
    De Marzo, Angelo M.
    ADVANCES IN ANATOMIC PATHOLOGY, 2008, 15 (06) : 319 - 331
  • [6] Genetic alterations as diagnostic markers in digestive tract cancer.
    LaurentPuig, P
    Flejou, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (5BIS): : B21 - B26
  • [7] Tumour markers in prostate cancer II: Diagnostic and prognostic cellular biomarkers
    Bjartell, Anders
    Montironi, Rodolfo
    Berney, Daniel M.
    Egevad, Lars
    ACTA ONCOLOGICA, 2011, 50 : 76 - 84
  • [8] Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications
    Eric C. Nelson
    Christopher P. Evans
    Chong-Xian Pan
    Primo N. Lara
    World Journal of Urology, 2007, 25 : 393 - 399
  • [9] Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications
    Nelson, Eric C.
    Evans, Christopher P.
    Pan, Chong-Xian
    Lara, Primo N., Jr.
    WORLD JOURNAL OF UROLOGY, 2007, 25 (04) : 393 - 399
  • [10] An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer
    Broenimann, Stephan
    Pradere, Benjamin
    Karakiewicz, Pierre
    Abufaraj, Mohammad
    Briganti, Alberto
    Shariat, Shahrokh F.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (08) : 841 - 850
12345